A Phase III (Phase I Closed) Randomized Study of Radiation Therapy and Temozolomide (IND #60,265) Versus Radiation Therapy and Nitrosourea for Anaplastic Astrocytoma and Mixed Anaplastic Oligoastrocytoma (Astrocytoma Dominant)
Principal Investigator
Susan Chang, MD
Status
Terminated
Date Opened To Accrual
June 16 2000
Date Closed to Accrual
March 30 2007
Date of Study Termination
May 14 2018
Disease Site
Brain [BN]
Other
Phase
I/III
Developmental Therapeutics
No
Primary Objective
To compare overall survival.
Data Collection Notice:
Data for this trial is being collected via the NRG/RTOG Data Center.
Patient Population
Histologically confirmed anaplastic astrocytoma by central review or mixed oligodendroglial/astrocytic tumors if the oligodroglial component is No prior irradiation to the head, neck, or chemotherapy for any reason.
-->
-->
-->
-->
-->
Target Accrual
454
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.